Related Articles
Heregulin-triggered Her-2/neu signaling enhances nuclear accumulation of p21WAF1/CIP1 and protects breast cancer cells from cisplatin-induced genotoxic damage
Clinical significance of p21WAF1/CIP1 and p53 expression in serous cystadenocarcinoma of the ovary
HER4 tumor expression in breast cancer patients randomized to treatment with or without tamoxifen
p21WAF1/CIP1 protein expression in primary ovarian cancer.
Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer